| Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology Guideline HS Rugo, RB Rumble, E Macrae, DL Barton, HK Connolly, MN Dickler, ... Journal of Clinical Oncology 34 (25), 3069-3103, 2016 | 666 | 2016 |
| Bevacizumab added to neoadjuvant chemotherapy for breast cancer HD Bear, G Tang, P Rastogi, CE Geyer Jr, A Robidoux, JN Atkins, ... New England Journal of Medicine 366 (4), 310-320, 2012 | 565 | 2012 |
| HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials A Gennari, MP Sormani, P Pronzato, M Puntoni, M Colozza, U Pfeffer, ... JNCI: Journal of the National Cancer Institute 100 (1), 14-20, 2008 | 504 | 2008 |
| Combination anastrozole and fulvestrant in metastatic breast cancer RS Mehta, WE Barlow, KS Albain, TA Vandenberg, SR Dakhil, ... New England Journal of Medicine 367 (5), 435-444, 2012 | 499 | 2012 |
| Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy A Cerussi, D Hsiang, N Shah, R Mehta, A Durkin, J Butler, BJ Tromberg Proceedings of the National Academy of Sciences 104 (10), 4014-4019, 2007 | 376 | 2007 |
| Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy BJ Tromberg, A Cerussi, N Shah, M Compton, A Durkin, D Hsiang, ... Breast Cancer Research 7, 1-7, 2005 | 329 | 2005 |
| MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy JH Chen, B Feig, G Agrawal, H Yu, PM Carpenter, RS Mehta, O Nalcioglu, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 246 | 2008 |
| Diffuse optical monitoring of blood flow<? xpp qa?> and oxygenation in human breast cancer during<? xpp qa?> early stages of neoadjuvant chemotherapy C Zhou, R Choe, N Shah, T Durduran, G Yu, A Durkin, D Hsiang, R Mehta, ... Journal of biomedical optics 12 (5), 051903-051903-11, 2007 | 238 | 2007 |
| Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment D Roblyer, S Ueda, A Cerussi, W Tanamai, A Durkin, R Mehta, D Hsiang, ... Proceedings of the National Academy of Sciences 108 (35), 14626-14631, 2011 | 186 | 2011 |
| Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative 1H MR Spectroscopy1 HM Baek, JH Chen, K Nie, HJ Yu, S Bahri, RS Mehta, O Nalcioglu, MY Su Radiology 251 (3), 653-662, 2009 | 183 | 2009 |
| Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial HD Bear, G Tang, P Rastogi, CE Geyer, Q Liu, A Robidoux, L Baez-Diaz, ... The lancet oncology 16 (9), 1037-1048, 2015 | 165 | 2015 |
| Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy AE Cerussi, VW Tanamai, D Hsiang, J Butler, RS Mehta, BJ Tromberg Philosophical transactions of the royal society A: mathematical, physical …, 2011 | 152 | 2011 |
| Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy S Ueda, D Roblyer, A Cerussi, A Durkin, A Leproux, Y Santoro, S Xu, ... Cancer research 72 (17), 4318-4328, 2012 | 149 | 2012 |
| Predicting responses to neoadjuvant chemotherapy in breast cancer: ACRIN 6691 trial of diffuse optical spectroscopic imaging BJ Tromberg, Z Zhang, A Leproux, TD O'Sullivan, AE Cerussi, ... Cancer research 76 (20), 5933-5944, 2016 | 142 | 2016 |
| Overall survival with fulvestrant plus anastrozole in metastatic breast cancer RS Mehta, WE Barlow, KS Albain, TA Vandenberg, SR Dakhil, ... New England Journal of Medicine 380 (13), 1226-1234, 2019 | 133 | 2019 |
| Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the … JA Zell, WY Tsang, TH Taylor, RS Mehta, H Anton-Culver Breast Cancer Research 11, 1-10, 2009 | 133 | 2009 |
| Independent association of angiogenesis index with outcome in prostate cancer R Mehta, A Kyshtoobayeva, T Kurosaki, EJ Small, H Kim, R Stroup, ... Clinical cancer research 7 (1), 81-88, 2001 | 123 | 2001 |
| The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature JF Reavey-Cantwell, RI Haroun, M Zahurak, RE Clatterbuck, RJ Parker, ... Journal of neuro-oncology 55, 195-204, 2001 | 122 | 2001 |
| Quantification of Choline-containing Compounds in Malignant Breast Tumors by 1H MR Spectroscopy Using Water as an Internal Reference at 1.5 T HM Baik, MY Su, H Yu, O Nalcioglu, R Mehta Magnetic Resonance Materials in Physics, Biology and Medicine 19, 96-104, 2006 | 112 | 2006 |
| Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients RW Holloway, RS Mehta, NJ Finkler, KT Li, CE McLaren, RJ Parker, ... Gynecologic oncology 87 (1), 8-16, 2002 | 106 | 2002 |
